Alterity Therapeutics Limited
ATHE
$3.43
-$0.02-0.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.16M | -3.15M | -1.59M | -1.56M | -2.34M |
| Total Depreciation and Amortization | 19.00K | 18.90K | 21.50K | 21.10K | 23.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 742.30K | 740.00K | 134.50K | 131.70K | 244.60K |
| Change in Net Operating Assets | -1.09M | -1.09M | 447.10K | 437.80K | -654.70K |
| Cash from Operations | -3.49M | -3.47M | -990.20K | -969.70K | -2.72M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.46M | 2.45M | -2.40M | -2.35M | -- |
| Cash from Investing | 2.46M | 2.45M | -2.40M | -2.35M | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -33.10K | -33.10K | -29.40K | -29.40K | -34.10K |
| Issuance of Common Stock | 10.19M | 10.19M | 21.09M | 21.09M | 199.30K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -554.10K | -554.10K | -1.37M | -1.37M | -16.00K |
| Cash from Financing | 6.30M | 6.28M | 12.61M | 12.35M | 97.20K |
| Foreign Exchange rate Adjustments | -12.70K | -12.60K | -50.40K | -49.40K | -13.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5.26M | 5.25M | 9.17M | 8.98M | -2.64M |